Olutasidenib + Sensitive Cyp3a Substrates Interaction
Majorinteraction on record
Description
Olutasidenib induces CYP3A and may decrease plasma concentrations of sensitive CYP3A substrates, reducing their efficacy. Avoid concomitant use or monitor for loss of therapeutic effect.
Mechanism
Olutasidenib induces CYP3A, decreasing substrate plasma concentrations
Source: NLP:olutasidenib